Data / Form D filings / Scilex Pharmaceuticals Inc.
Scilex Pharmaceuticals Inc.: Form D filings
Scilex Pharmaceuticals Inc., a pharmaceuticals company in Malvern, PA, filed 5 Form D notices with the SEC between 2014 and 2016. The latest, on May 17, 2016, reports $479,930 sold of a $479,930 offering to 9 investors.
Find out what Scilex Pharmaceuticals Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 301 LINDENWOOD DR., SUITE 300, Malvern, PA, 19355
- Phone
- (610) 644-5352
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2012
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1603542
The full lists. Form D filings in Pennsylvania: 987 rows, $49.35, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 17, 2016 | New notice | $479,930 | $479,930 | $0 | 9 | May 4, 2016 | sec.gov |
| Mar 31, 2015 | New notice | $2,025,274 | $2,025,274 | $0 | 3 | Mar 26, 2015 | sec.gov |
| Aug 7, 2014 | New notice | $5,001,700 | $0 | $5,001,700 | 0 | Yet to occur | sec.gov |
| Aug 4, 2014 | Amendment | $5,250,000 | $5,001,700 | $248,300 | 12 | Mar 20, 2014 | sec.gov |
| Mar 26, 2014 | New notice | $5,250,000 | $5,001,700 | $248,300 | 12 | Mar 20, 2014 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Jerrold Sendrow | Director | |
| William Pedranti | Executive Officer, Director | |
| Anthony Mack | Executive Officer, Director | |
| Eric Floyd | Director |
Other pharmaceuticals companies in Pennsylvania that filed recently
- Telemachus Therapeutics, Inc. $375,000 · Oct 28, 2026
- EpiVario Inc. $185,000 · Oct 13, 2026
- Maxona Pharmaceuticals, Inc. $5.8 million · Aug 14, 2026
Every Form D from the week of May 16, 2016 · All recent filings in Pennsylvania · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Scilex Pharmaceuticals Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.